Isogai Noritaka, Morotomi Tadaaki, Hayakawa Sumio, Munakata Hiroshi, Tabata Yasuhiko, Ikada Yoshito, Kamiishi Hiroshi
Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, 377-2 Ono-higashi, Osaka-Sayama, Osaka, Japan 589-8511.
J Biomed Mater Res A. 2005 Sep 1;74(3):408-18. doi: 10.1002/jbm.a.30343.
Basic fibroblast growth factor (b-FGF) may have a role in tissue-engineered chondrogenesis. However, when applied in solution, b-FGF rapidly diffuses from the implant site. In another approach for tissue engineering, poly-lactide-based copolymers have shown promise as scaffolds for chondrocytes used to tissue engineer auricular cartilage in the shape of an ear. This study evaluated the effectiveness of b-FGF impregnated in gelatin microspheres to achieve slow growth factor release for augmenting the in vivo chondrogenic response. Whereas 125I-labeled b-FGF injected in solution showed rapid in vivo clearance from the injection site (only 3% residual after 24 h), when incorporated into gelatin microspheres, 44% and 18% of the b-FGF remained at 3 and 14 days, respectively. Canine chondrocytes were isolated and grown in vitro onto ear-shaped poly-lactide/caprolactone copolymers for 1 week, then implanted into the dorsal subcutaneous tissue of nude mice; implants contained b-FGF either in free solution or in gelatin microspheres. A third group underwent preinjection of b-FGF in gelatin microspheres 4 days before chondrocyte-copolymer implantation. The implants with b-FGF-incorporated microspheres showed the greatest chondrogenic characteristics at 5 and 10 weeks postoperatively: good shape and biomechanical trait retention, strong (histologic) metachromasia, rich vascularization of surrounding tissues, and increased gene expression for type II collagen (cartilage marker) and factor VIII-related antigen (vascular marker). In the case of implant site preadministration with b-FGF-impregnated microspheres, the implant architecture was not maintained as well, and reduced vascularization and metachromasia was also apparent. In conclusion, these findings indicate that a sustained release of b-FGF augments neovascularization and chondrogenesis in a tissue-engineered cartilage construct.
碱性成纤维细胞生长因子(b-FGF)可能在组织工程软骨形成中发挥作用。然而,当以溶液形式应用时,b-FGF会迅速从植入部位扩散。在另一种组织工程方法中,聚乳酸基共聚物已显示出有望作为软骨细胞的支架,用于构建耳朵形状的耳廓软骨组织工程。本研究评估了明胶微球中浸渍的b-FGF实现生长因子缓慢释放以增强体内软骨生成反应的有效性。溶液中注射的125I标记的b-FGF在体内从注射部位迅速清除(24小时后仅残留3%),而当掺入明胶微球中时,分别在3天和14天时b-FGF仍有44%和18%残留。分离犬软骨细胞并在体外培养于耳朵形状的聚乳酸/己内酯共聚物上1周后,植入裸鼠背部皮下组织;植入物中含有游离溶液形式或明胶微球形式中的b-FGF。第三组在软骨细胞-共聚物植入前4天预先注射明胶微球中的b-FGF。含有b-FGF微球的植入物在术后5周和10周时显示出最大的软骨生成特征:形状良好且生物力学特性得以保留、强烈的(组织学)异染性、周围组织丰富的血管化以及II型胶原蛋白(软骨标志物)和VIII因子相关抗原(血管标志物)的基因表达增加。在植入部位预先给予b-FGF浸渍微球的情况下,植入物结构维持不佳,血管化和异染性降低也很明显。总之,这些发现表明b-FGF的持续释放增强了组织工程软骨构建物中的新生血管形成和软骨生成。